Alfred Mann - Second Sight Chairman
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
Chairman
Mr. Alfred E. Mann is appointed as Chairman Emeritus of Second Sight Medical Products Inc. effective August 18 2015. He was a director of MannKind Corporation since April 1999 its Chairman of the Board since December 2001 and its Chief Executive Officer since October 2003. He retired as Chief Executive Officer of MannKind Corporation effective January 9 2015 and is currently its Executive Chairman. He founded and formerly served as Chairman and Chief Executive Officer of MiniMed Inc. a publicly traded company focused on diabetes therapy and micro infusion drug delivery that was acquired by Medtronic Inc. in August 2001. Mr. Mann also founded and from 1972 through 1992 served as Chief Executive Officer of Pacesetter Systems Inc. and its successor Siemens Pacesetter Inc. a manufacturer of cardiac pacemakers now the Cardiac Rhythm Management Division of St. Jude Medical Corporationrationration. Mr. Mann founded and since 1993 has served as Chairman and until January 2008 as CoChief Executive Officer of Advanced Bionics Corporation a medical device manufacturer focused on neurostimulation to restore hearing to the deaf and to treat chronic pain and other neural deficits that was acquired by Boston Scientific Corporation in June 2004. In January 2008 the former stockholders of Advanced Bionics Corporation repurchased certain segments from Boston Scientific Corporation and formed Advanced Bionics LLC for cochlear implants and Infusion Systems LLC for infusion pumps. Mr. Mann was nonexecutive Chairman of both entities. Advanced Bionics LLC was acquired by Sonova Holdings on December 30 2009 since 2015.
| Age | 89 |
| Tenure | 9 years |
| Phone | 818 833-5000 |
| Web | www.secondsight.com |
Second Sight Management Efficiency
The company has return on total asset (ROA) of (10.74) % which means that it has lost $10.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.02) %, meaning that it created substantial loss on money invested by shareholders. Second Sight's management efficiency ratios could be used to measure how well Second Sight manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 199 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Second Sight Medical has a current ratio of 24.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Second Sight until it has trouble settling it off, either with new capital or with free cash flow. So, Second Sight's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Second Sight Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Second to invest in growth at high rates of return. When we think about Second Sight's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 6 records | CHAIRMAN Age | ||
| Jerry Nix | Genuine Parts Co | 71 | |
| Tadashi Yanai | Fast Retailing Co | 74 | |
| Thomas Gallagher | Genuine Parts Co | 70 | |
| Michael Bless | Century Aluminum | 52 | |
| Terence Wilkinson | Century Aluminum | 71 | |
| Jean Douville | Genuine Parts Co | 70 | |
Management Performance
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 |
Second Sight Medical Leadership Team
Elected by the shareholders, the Second Sight's board of directors comprises two types of representatives: Second Sight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Second. The board's role is to monitor Second Sight's management team and ensure that shareholders' interests are well served. Second Sight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Second Sight's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Blake, CFO | ||
| Patrick Ryan, COO | ||
| Frank Vandeputte, Vice President General Manager | ||
| Anthony Moses, Commercial Vice President - Americas | ||
| Edward Randolph, VP of Manufacturing | ||
| Gregg Williams, Independent Director | ||
| Alfred Mann, Co-Founder, Chairman Emeritus, Member of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee | ||
| Jonathan McGuire, President CEO, Director | ||
| Stephen Okland, Commercial Vice President U.S. and Canada | ||
| Gregoire Cosendai, VP of European Operations | ||
| Steven Okland, Commercial Vice President U.S. and Canada | ||
| William Link, Independent Director | ||
| Thomas Miller, CFO | ||
| James Miller, Director - Manufacturing | ||
| Will McGuire, President CEO, Director | ||
| David Jacques, Vice President - Research & Development | ||
| Aaron Mendelsohn, Director | ||
| Robert Greenberg, President CEO, Director | ||
| Matthew Pfeffer, Independent Director |
Second Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Second Sight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 39.41 M | |||
| Shares Owned By Insiders | 28.61 % | |||
| Shares Owned By Institutions | 7.01 % | |||
| Number Of Shares Shorted | 1.19 M | |||
| Price To Earning | (1.61) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 616.54 X |
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
| 0.62 | MDT | Medtronic PLC Sell-off Trend | PairCorr |
Moving against Second Stock
| 0.72 | JPHLF | Japan Post Holdings | PairCorr |
| 0.7 | MZHOF | Mizuho Financial | PairCorr |
| 0.67 | BSX | Boston Scientific Corp Earnings Call This Week | PairCorr |
| 0.6 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
| 0.6 | ALGN | Align Technology Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |